Translational Science

Research and development pipelines are filled with a large number of investigational products—most of which fail in clinical trials, draining corporate resources, disappointing investors, and shattering patients’ hopes. To help solve this productivity puzzle for biopharmaceutical companies, Syneos Health™ offers an attractive integrated suite of translational science capabilities for efficient preclinical and early clinical assessment and prioritization of drug candidates. This operational support and scientific consultancy enables you to more effectively focus investment on candidates that are most promising, with the greatest potential to impact human health.

Download our Fact Sheet